No adverse outcome (without severe morbidity) |
Adverse outcome* (severe morbidity) |
p | |
---|---|---|---|
Maternal |
31.8±3.64 | 31.2±4.9 | 0.53 |
Nulliparity |
27 (69.2%) | 10 (71.4%) | 0.88 |
Preeclampsia |
1 (2.6%) | 2 (14.6%) | 0.94 |
Gesta |
20 (51.3%) | 5 (35.7%) | 0.32 |
1 (2.6%) | 2 (14.6%) | 0.10 | |
Oligohydramnion |
12 (30.8%) | 5 (35.7%) | 0.44 |
Gestational age at FGR diagnosis^ (weeks) |
32.15±2.65 | 28.5±2.88 |
No adverse outcome (without severe morbidity) |
Adverse outcome * (severe morbidity) |
p | |
---|---|---|---|
1416±402 | 774±447 | ||
Infant |
14 (35.9%) | 9 (64.3%) | |
1st minute Apgar score |
7.8±1.7 | 4.3±3 | |
8.7±1.1 | 8±2.4 | 0.84 |
No adverse outcome (without severe morbidity) |
Adverse outcome * (severe morbidity) |
P | |
---|---|---|---|
Gestational age at delivery (weeks)^ |
32.8±2.64 | 29.2±3.02 | |
Indications for delivery: |
37(94.9%) 5 (12.8%) | 13(92.9%) 1(7.1%) | 0.78 0.56 |
Cesarean section |
38 (97.4%) | 13 (92.9%) | 0.44 |
1 (2.6%) | 1 (7.1%) | 0.96 |